Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	44.41	61.58	9.24	20.99	55.89	63.83
Short-Term Investments	167.3	165.34	-	22.76	-	-
Cash & Short-Term Investments	211.7	226.92	9.24	43.76	55.89	63.83
Cash Growth	17.19%	2356.33%	-78.89%	-21.71%	-12.44%	2568.39%
Accounts Receivable	0.08	0.12	1.17	1.36	1.61	2.01
Other Receivables	-	1.37	0.01	0	0.02	0.03
Receivables	0.08	1.48	1.18	7.47	1.63	2.05
Inventory	-	-	-	-	1.4	0.98
Prepaid Expenses	3.96	2.68	1.08	0.44	0.39	0.42
Other Current Assets	-	0.08	5.35	1.54	0.03	0.03
Total Current Assets	215.74	231.16	16.84	53.22	59.33	67.3
Property, Plant & Equipment	63.24	59.54	6.32	0.37	2.49	2.73
Long-Term Investments	-	0.13	0.13	0.15	-	-
Goodwill	-	-	24.06	-	-	-
Other Intangible Assets	50	50.01	50.35	0.03	0.11	0.13
Other Long-Term Assets	0.37	0.27	0.18	4.33	2.52	0.26
Total Assets	329.35	341.1	97.89	58.09	64.44	70.42
Accounts Payable	8.23	9.84	6.41	1.54	0.97	0.73
Accrued Expenses	2.91	5.48	3.59	1.3	1.03	0.82
Current Portion of Long-Term Debt	0.05	0.05	0.05	-	-	-
Current Portion of Leases	0.98	0.96	0.05	-	0.27	0.25
Current Unearned Revenue	-	1.4	-	-	-	-
Other Current Liabilities	0.5	0.5	5.57	0.28	-	-
Total Current Liabilities	12.68	18.23	15.66	3.12	2.27	1.8
Long-Term Debt	1.61	1.63	1.68	-	-	-
Long-Term Leases	1.17	1.43	0.78	-	0.26	0.52
Long-Term Unearned Revenue	26.6	26.6	-	-	-	-
Long-Term Deferred Tax Liabilities	2.5	2.5	4.59	-	-	-
Other Long-Term Liabilities	0.15	0.06	-	0.33	0.64	0.69
Total Liabilities	44.7	50.43	22.71	3.45	3.16	3.01
Common Stock	0.07	0.07	0.03	0.14	0.14	0.14
Additional Paid-In Capital	534.45	522.37	227.59	160.43	159.73	158.59
Retained Earnings	-249.9	-231.72	-152.44	-105.93	-98.6	-91.33
Comprehensive Income & Other	0.02	-0.05	-	-	-	-
Total Common Equity	284.65	290.67	75.18	54.64	61.28	67.41
Shareholders' Equity	284.65	290.67	75.18	54.64	61.28	67.41
Total Liabilities & Equity	329.35	341.1	97.89	58.09	64.44	70.42
Total Debt	3.82	4.06	2.55	-	0.52	0.78
Net Cash (Debt)	207.88	222.85	6.69	43.76	55.37	63.05
Net Cash Growth	16.94%	3232.64%	-84.72%	-20.97%	-12.19%	4445.93%
Net Cash Per Share	2.96	3.46	0.25	3.08	3.90	6.07
Filing Date Shares Outstanding	74.23	74.05	58.69	28	14.21	14.19
Total Common Shares Outstanding	74.05	70.67	28.18	14.21	14.2	14.19
Working Capital	203.06	212.93	1.17	50.1	57.06	65.5
Book Value Per Share	3.84	4.11	2.67	3.84	4.31	4.75
Tangible Book Value	234.65	240.66	0.76	54.62	61.17	67.28
Tangible Book Value Per Share	3.17	3.41	0.03	3.84	4.31	4.74
Land	0.92	0.92	1.28	0.37	0.37	0.37
Buildings	1.77	1.77	1.77	-	-	-
Machinery	11.68	11.42	2.68	0.02	4.44	4.2
Leasehold Improvements	3.57	3.57	0.18	-	4.14	4.14

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q